© InventisBio Co., Ltd 沪ICP备2021024579号-1 沪公网安备31011502020033
Yaolin Wang, PhD
Chairman & CEO
> 20 yrs of oncology research, pharmaceutical R&D experience in both small molecules and biologics
Led Merck (MSD) external oncology/in vivo pharmacology
Twice received Schering-Plough President Award for Innovative Drug Discovery
Yueheng Jiang, PhD
Vice President, Board Secretary & Director
14 yrs of medicinal chemistry experience at Schering-Plough and Merck
5 yrs as VP of Process R&D at ABAChem
Led CMC development of 4 clinical candidates at InventisBio
Xing Dai, PhD
Vice President & Director
> 15 yrs of pharmaceutical R&D experience Led the medicinal chemistry in the discovery of 8 clinical candidates American Chemical Society Young Investigator; Merck Excellence Award, SAPA EC and Deputy Director
Ling Zhang, PhD
Chief Medical Officer & Vice President
Dr. Ling Zhang is fully responsible for overseeing the implementation and advancement of the company’s clinical projects. With over 20 years of experience in clinical research, Dr. Zhang has held senior clinical leadership roles at several major international pharmaceutical companies, including GlaxoSmithKline, Johnson & Johnson, Sanofi, Schering-Plough, Merck, and Daiichi Sankyo. She has participated in the design and leadership of global clinical trials for several successful marketed drugs, including Merck's PD-1 antibody Keytruda® for melanoma. Dr. Zhang graduated with a bachelor's degree from the Shanghai Medical College of Fudan University (formerly Shanghai Medical University) and earned her Ph.D. from Temple University in the United States.
- > 20 yrs of oncology research, pharmaceutical R&D experience in both small molecules and biologics
- Led Merck (MSD) external oncology/in vivo pharmacology
- Twice received Schering-Plough President Award for Innovative Drug Discovery
Jack Jiang, PhD
SVP
- 14 yrs of medicinal chemistry experience at Schering-Plough and Merck
- 5 yrs as VP of Process R&D at ABAChem
- Led CMC development of 4 clinical candidates at InventisBio
David Dai, PhD
SVP
- > 15 yrs of pharmaceutical R&D experience
- Led the medicinal chemistry in the discovery of 8 clinical candidates
- American Chemical Society Young Investigator; Merck Excellence Award, SAPA EC and Deputy Director
Ling Zhang, MD, PhD CMO
- > 20 yrs of oncology clinical development experience covering small molecules and biologics at GSK, Sanofi, Schering-Plough, Merck and Daiichi Sankyo
- Designed and managed clinical trials leading to approval and marketing of 5 blockbuster drugs
